Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:419-420 (21 February), doi:10.1136/bmj.328.7437.419
Children benefit the most as do many adults
| The first 150 words of the full text of this article appear below. |
Multichannel cochlear implant systems were approved by the Food and Drug Administration for adults in 1985 and for children in 1990. NHS funding became available in the early 1990s. About 4000 patients have received implants in the United Kingdom (50 000 worldwide). Children now outnumber adults by 2:1. Cochlear implants are reliable, and cochlear implant surgery is safe despite recent concerns regarding a risk of meningitis. The numbers of suitable candidates is rising as selection criteria change, and it is timely to consider the benefits and risks of the technique.
A cochlear implant takes the place of the damaged organ of Corti and stimulates the spiral ganglion cells directly. Acquired causes of hair cell loss include infection such as rubella, cytomegalovirus infection, mumps, measles, meningitis, and middle ear infection, drug toxicity, trauma, and autoimmune disease, as well as Menière's disease and cochlear otosclerosis. Congenital hair cell loss may be due
Richard T Ramsden, professor of otolaryngology
Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL richard.ramsden@man.ac.uk
Read all Rapid Responses